医学
卡铂
多西紫杉醇
乳腺癌
肿瘤科
内科学
彭布罗利珠单抗
三阴性乳腺癌
蒽环类
人口
养生
癌症
化疗
免疫疗法
环境卫生
顺铂
作者
Priyanka Sharma,Shane R. Stecklein,Rachel Yoder,Joshua M. Staley,Kelsey Schwensen,Anne O’Dea,Lauren Nye,Deepti Satelli,Gregory Crane,Rashna Madan,Maura O’Neil,Jamie L. Wagner,Kelsey E. Larson,Christa Balanoff,Lyndsey J. Kilgore,Milind A. Phadnis,Andrew K. Godwin,Roberto Salgado,Qamar J. Khan,Joyce O’Shaughnessy
出处
期刊：JAMA Oncology
[American Medical Association]
日期：2023-11-22
卷期号：10 (2): 227-227
被引量：60
标识
DOI：10.1001/jamaoncol.2023.5033
摘要
Addition of pembrolizumab to anthracycline-based chemotherapy improves pathologic complete response (pCR) and event-free survival (EFS) in triple-negative breast cancer (TNBC). The efficacy of anthracycline-free chemoimmunotherapy in TNBC has not been assessed.
科研通智能强力驱动
Strongly Powered by AbleSci AI
SYLH
Andy_Cheung
cdercder
请叫我风吹麦浪
昏睡的蟠桃
Oracle
一一
彭于彦祖
pluto
子车茗
默默地读文献
科研小民工
pcr163
yanzu
迷人秋烟
亘古匆匆
nozero
我真的不是robot
Jackylee
坚强的广山
皖公网安备34019202002308
